Another international member has joined, bringing the total number of members in the Yinfeng Life Extension Program to 241.
Release time:
2024-11-13
"With infinite hope for future medical technology, I applied to become a member of the Yinfeng Life Extension Program and volunteered to contribute to cryobiology in a hundred years by becoming a cryonics volunteer. I also believe that preservation in China is safer."
——Larry Lee (Canada)

This marks the 241st membership application received by the Yinfeng Life Sciences Research Institute (hereinafter referred to as: Yinfeng Life Sciences). It is also the 5th international member newly added to the Yinfeng Life Extension Program. As an emerging scientific research project in China, the Yinfeng Life Extension Program has received increasing support from the public. Some hold firm belief in future technology, some harbor boundless attachment to life in this world, some are selflessly dedicated to medical progress, and some are deeply reluctant to part with their loved ones. With the export of the YF series programmed cooling equipment and the establishment of the International Life Extension Research Alliance, the Yinfeng Life Extension Program has gradually gained attention and recognition from the public abroad, becoming a true representative of China's influence in the field of cryobiomedicine.
As of now, the Yinfeng Life Extension Program has recruited a total of 241 members and 69 volunteers, including 24 volunteers involved in human cryopreservation and rewarming technology research. Volunteers/members come from 26 provinces/municipalities across the country, the Hong Kong Special Administrative Region, and overseas (Malaysia, the United States, Canada).
Research on human cryopreservation and rewarming technology is a legitimate and scientifically based effort aimed at preserving the human body with the most advanced technology available. Considering future developments in technologies such as nanoscale molecular repair, highly advanced computing, precise control of cell growth, and tissue regeneration, transcending the river of time may no longer be a distant dream. Previously, an open website in the United States showed that 78 experts and scholars from fields including biology, cryobiology, neuroscience, natural sciences, nanotechnology and computing, and ethics signed a public declaration expressing support for cryopreservation technology.
Currently, nearly 5,000 members worldwide plan to participate in the cryopreservation project, and more than 600 people have already completed cryopreservation.
Today, the scientific community is advancing cryobiomedicine, regenerative medicine, and nanotechnology at an unprecedented pace, laying the groundwork for the feasibility of cryopreservation technology. We believe that with the joint efforts of researchers worldwide and the shared support of global members, cryobiomedicine will bring about groundbreaking innovations and become a reality that benefits human society. Despite facing various difficulties and challenges, this beautiful expectation and firm belief in the future will guide us toward more distant horizons.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.